Organ-Preserving Surgery in Urethral Cancer (a Clinical Case)

Author:

Kholopova N. S.1ORCID,Venskel V. B.1ORCID,Kovalenko N. V.2ORCID,Zhavoronkova V. V.2ORCID,Ivanov A. I.3ORCID,Chuhnin A. G.4ORCID,Klimchenko A. A.4ORCID

Affiliation:

1. Volgograd Regional Clinical Oncology Dispensary

2. Volgograd State Medical University; Volgograd Regional Clinical Oncology Dispensary

3. Volgograd State Medical University; Volgograd Regional Clinical Oncology Dispensary

4. Volgograd State Medical University

Abstract

Background. Despite low incidence, malignant urethral neoplasms are among the most aggressive tumours. Prevalence of muscle-invasive and metastatic cancer at diagnosis, as well as a high relapse rate compel adherence to the most radical treatment. At the same time, the high incidence of urethral tumours in elderly and senile patients and high postoperative complication rates warrant the development of organ-preserving treatment.Aim. A case description to verify the organ-preserving treatment applicability in urethral cancer.Materials and methods. We report the treatment experience in a senile patient with concomitant chronic kidney disease at the Volgograd Regional Clinical Oncology Dispensary’s Oncourology Unit. Accounting for the age, concomitant pathology and tumour histology factors, a minimally invasive organ-preserving surgical intervention was performed as laparoscopic urethral resection with ureterocystoneostomy.Results and discussion. Renal function was assessed in postoperative period with dynamic nephroscintigraphy and blood creatinine monitoring. Control cysto-, ureteroscopy and contrast-enhanced CT scanning in areas of interest were performed to rule out relapse and progression.Conclusion. No report of disease relapse or progression at follow-up indicates the oncological safety of organ-preserving surgery in this patient category. Th is approach also gains support from immediate and long-term outcomes of the patient’s improved renal function and sustained good quality of life.

Publisher

Bashkir State Medical University

Subject

General Engineering,Energy Engineering and Power Technology

Reference15 articles.

1. Upper tract urothelial cancer: clinical guidelines: ICD С65, С66. Age group: adults, children. Moscow, 2020 (In Russ.).

2. Tailakov B.B., Davranov A.Zh., Alibekova B.S., Abdikarimov A.M., Rutzhanuly I. Surgical management of malignant tumors of the upper urinary tract. Herald of Almaty State Institute of Advanced Medical Education. 2014;3:179–81 (In Russ.).

3. Kaprin A.D., Starinsky V.V., Shakhzadova A.O. State of cancer care for population in Russia in 2020. Moscow: P.A Gertsen Moscow Research Oncology Institute — branch of the National Medical Research Center for Radiology, 2020.

4. Geavlete P.A. (ed.) Percutaneos surgery of the upper urinary tract. Handbook of endourology. Elsevier; 2016.

5. Bokovoj S.P., Zverev Y.A. Ureteral tumors. Complex clinical cases. Urology reports. 2019;9(2):47–52 (In Russ.). DOI: 10.17816/ uroved9247-52

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3